| Dr Martin F Lansang, MD | |
|
1 Wescott Dr, Suite 102, Flemington, NJ 08822-4655 | |
| (908) 237-1148 | |
| (908) 237-1318 |
| Full Name | Dr Martin F Lansang |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 32 Years |
| Location | 1 Wescott Dr, Flemington, New Jersey |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407801269 | NPI | - | NPPES |
| 0111805 | Medicaid | NJ | |
| 110285 | Other | NJ | MEDICARE ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 25MA08042700 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hunterdon Medical Center | Flemington, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hunterdon Specialty Care Pc | 4587966601 | 83 |
News Archive
These findings, which were published online March 20 in the Journal of Biological Chemistry and will be in press on May 4, offer hope for a more selective, less toxic therapy for leukemia.
The leopard cannot change its spots, nor can the tiger change its stripes, but a new research report published in the January 2009 issue of the journal GENETICS tells us something about how cats end up with their spots and stripes
Partnering with head and neck surgeons, pathologists at Dartmouth Hitchcock Medical Center's Norris Cotton Cancer Center developed a new use for an old test to determine if a patient's cancer is recurring, or if the biopsy shows benign inflammation of mucosal tissues. In Pathology - Research and Practice, lead author Candice C. Black, DO explained how her team confirmed the utility of ProExC, an existing antibody cocktail commonly used for pathology tests of the uterine cervix.
HIV/Aids prevention campaigns which take into account changing sexual trends and social norms are more effective than campaigns which ignore them, according to the results of a series of surveys conducted in France. The findings will be published in the forthcoming issue of AIDS, the leading journal in the field of HIV and AIDS research.
People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21 to April 28, 2012.
› Verified 9 days ago
| Entity Name | Professional Service Fund Of Deborah Heart & Lung Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407803596 PECOS PAC ID: 4284537499 Enrollment ID: O20040127000717 |
News Archive
These findings, which were published online March 20 in the Journal of Biological Chemistry and will be in press on May 4, offer hope for a more selective, less toxic therapy for leukemia.
The leopard cannot change its spots, nor can the tiger change its stripes, but a new research report published in the January 2009 issue of the journal GENETICS tells us something about how cats end up with their spots and stripes
Partnering with head and neck surgeons, pathologists at Dartmouth Hitchcock Medical Center's Norris Cotton Cancer Center developed a new use for an old test to determine if a patient's cancer is recurring, or if the biopsy shows benign inflammation of mucosal tissues. In Pathology - Research and Practice, lead author Candice C. Black, DO explained how her team confirmed the utility of ProExC, an existing antibody cocktail commonly used for pathology tests of the uterine cervix.
HIV/Aids prevention campaigns which take into account changing sexual trends and social norms are more effective than campaigns which ignore them, according to the results of a series of surveys conducted in France. The findings will be published in the forthcoming issue of AIDS, the leading journal in the field of HIV and AIDS research.
People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21 to April 28, 2012.
› Verified 9 days ago
| Entity Name | Deborah Cardiovascular Group, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821041732 PECOS PAC ID: 7618962549 Enrollment ID: O20040419001227 |
News Archive
These findings, which were published online March 20 in the Journal of Biological Chemistry and will be in press on May 4, offer hope for a more selective, less toxic therapy for leukemia.
The leopard cannot change its spots, nor can the tiger change its stripes, but a new research report published in the January 2009 issue of the journal GENETICS tells us something about how cats end up with their spots and stripes
Partnering with head and neck surgeons, pathologists at Dartmouth Hitchcock Medical Center's Norris Cotton Cancer Center developed a new use for an old test to determine if a patient's cancer is recurring, or if the biopsy shows benign inflammation of mucosal tissues. In Pathology - Research and Practice, lead author Candice C. Black, DO explained how her team confirmed the utility of ProExC, an existing antibody cocktail commonly used for pathology tests of the uterine cervix.
HIV/Aids prevention campaigns which take into account changing sexual trends and social norms are more effective than campaigns which ignore them, according to the results of a series of surveys conducted in France. The findings will be published in the forthcoming issue of AIDS, the leading journal in the field of HIV and AIDS research.
People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21 to April 28, 2012.
› Verified 9 days ago
| Entity Name | Hunterdon Specialty Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306216874 PECOS PAC ID: 4587966601 Enrollment ID: O20160106002688 |
News Archive
These findings, which were published online March 20 in the Journal of Biological Chemistry and will be in press on May 4, offer hope for a more selective, less toxic therapy for leukemia.
The leopard cannot change its spots, nor can the tiger change its stripes, but a new research report published in the January 2009 issue of the journal GENETICS tells us something about how cats end up with their spots and stripes
Partnering with head and neck surgeons, pathologists at Dartmouth Hitchcock Medical Center's Norris Cotton Cancer Center developed a new use for an old test to determine if a patient's cancer is recurring, or if the biopsy shows benign inflammation of mucosal tissues. In Pathology - Research and Practice, lead author Candice C. Black, DO explained how her team confirmed the utility of ProExC, an existing antibody cocktail commonly used for pathology tests of the uterine cervix.
HIV/Aids prevention campaigns which take into account changing sexual trends and social norms are more effective than campaigns which ignore them, according to the results of a series of surveys conducted in France. The findings will be published in the forthcoming issue of AIDS, the leading journal in the field of HIV and AIDS research.
People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21 to April 28, 2012.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Martin F Lansang, MD 1 Wescott Dr, Suite 102, Flemington, NJ 08822-4655 Ph: (908) 237-1148 | Dr Martin F Lansang, MD 1 Wescott Dr, Suite 102, Flemington, NJ 08822-4655 Ph: (908) 237-1148 |
News Archive
These findings, which were published online March 20 in the Journal of Biological Chemistry and will be in press on May 4, offer hope for a more selective, less toxic therapy for leukemia.
The leopard cannot change its spots, nor can the tiger change its stripes, but a new research report published in the January 2009 issue of the journal GENETICS tells us something about how cats end up with their spots and stripes
Partnering with head and neck surgeons, pathologists at Dartmouth Hitchcock Medical Center's Norris Cotton Cancer Center developed a new use for an old test to determine if a patient's cancer is recurring, or if the biopsy shows benign inflammation of mucosal tissues. In Pathology - Research and Practice, lead author Candice C. Black, DO explained how her team confirmed the utility of ProExC, an existing antibody cocktail commonly used for pathology tests of the uterine cervix.
HIV/Aids prevention campaigns which take into account changing sexual trends and social norms are more effective than campaigns which ignore them, according to the results of a series of surveys conducted in France. The findings will be published in the forthcoming issue of AIDS, the leading journal in the field of HIV and AIDS research.
People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21 to April 28, 2012.
› Verified 9 days ago
Dr. Jeffrey D Hartford, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 Wescott Dr, Suite 201, Flemington, NJ 08822 Phone: 908-788-6504 Fax: 908-788-6458 | |
Devi Patel, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 Wescott Dr Ste 206, Flemington, NJ 08822 Phone: 908-788-6448 Fax: 908-483-4004 | |
Daniel Kobe, Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 1100 Wescott Dr Ste G3, Flemington, NJ 08822 Phone: 908-788-1710 | |
Kiera Farry, D.O. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 Wescott Dr Ste G3, Flemington, NJ 08822 Phone: 908-788-1710 | |
Dr. Mary Jean Fusco, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 4 Ups N Downs Ct, Flemington, NJ 08822 Phone: 908-782-0493 | |
Donald Stuart Novy, M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 6 Sand Hill Rd Ste 201, Flemington, NJ 08822 Phone: 908-237-4072 Fax: 908-782-7195 | |
Glen Erik Tonnessen, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 Wescott Drive, Suite G 3, Flemington, NJ 08822 Phone: 908-788-1710 Fax: 908-788-1716 |